Company News

FDA Releases Draft Guidance on Nanotechnology

No regulatory definition yet, but a "first step" to narrow discussion.

Author Image

By: TOM BRANNA

Editor

The U.S. Food and Drug Administration has released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology. The guidance outlines the agency’s view on whether regulated products contain nanomaterials or involve the application of nanotechnology. The draft guidance, “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” is available online and open for public comment. It represents the first ste...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters